Obermatt

CKD Bio

KSC:063160 · KR7063160006
PharmaceuticalsSmall

360° View

no current rank
Price/Sales66
Price/Earnings
Price/Book74
Dividend Yield1
Revenue Growth89
Profit Growth73
Capital Growth56
TSR 52w11
Leverage11
Liquidity10
Refinancing98
Combined36
Analyst Opinions
Pro Holdings15
Opinion Changes
Market Pulse1

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Employees33
Websiteckdbio.com
ISINKR7063160006
Last UpdateApr 2, 2026
Index & Theme
ManufacturingMedicalPharmaceutical

Description

Similar Stocks

The companies this stock is ranked against.

Compare CKD Bio with its peers
Chongkundang Holdings
KSC:001630
56
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Dongwha Pharm
KSC:000020
44
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kyongbo Pharmaceutical
KSC:214390
11
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Reyon Pharmaceutical
KSC:102460
16
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Hana Pharm
KSC:293480
88
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
PharmGen Science
KSC:004720
74
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →